|
Research
objectives
The British Association of Surgical Oncology Trial into the primary
treatment of small well-differentiated, special type, node negative
tumours of the breast (BASO II) is very simple in design. It asks a
relevant question - what is the best mode of treatment of these tumours of
low aggressive potential, which are commonly seen at breast screening
detection.
All the surgeons who treat these cases have been identified by the BASO
breast surgeons group and many of them attend study days arranged for this
group. Nevertheless recruitment of this trial has been poor.
This seems an ideal trial for examining the question of why recruitment to
clinical trials is often difficult. Here we have a group of surgeons who
have committed themselves to specialise in breast disease, a ready sample
of tumours, simple study with no complex ethical issues (such as bad side
effects) in any of the arms under consideration.
Further
information can be obtained from:
Professor Roger Blamey
Professor of Surgical Science
Professorial Unit of Surgery
The University of Nottingham
City Hospital
Hucknall Road
Nottingham, NG5 1PB
UK
|